Identification of the Plasmodium vivax mdr-like gene (pvmdr1) and analysis of single-nucleotide polymorphisms among isolates from different areas of endemicity

Journal of Infectious Diseases

Volumn 191, Issue 2, 2005, Pages 272-277

  Brega, Sara ^a   Meslin, Benoit ^a   De Monbrison, Frédérique ^a,b   Severini, Carlo ^f   Gradoni, Luigi ^f   Udomsangpetch, Rachanee ^d   Sutanto, Inge ^e   Peyron, François ^a,c   Picot, Stéphane ^a,b  

^a UNIVERSITÉ LYON 1   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c CROIX ROUSSE HOSPITAL   (France)

^d MAHIDOL UNIVERSITY   (Thailand)

^e UNIVERSITY OF INDONESIA   (Indonesia)

^f ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR MARKER;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; CODON; DNA DETERMINATION; ENDEMIC DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; ORTHOLOGY; PARASITE IDENTIFICATION; PARASITE ISOLATION; PLASMODIUM VIVAX; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AMINO ACID SEQUENCE; ANIMALS; DRUG RESISTANCE; ENDEMIC DISEASES; HUMANS; MOLECULAR SEQUENCE DATA; P-GLYCOPROTEIN; PLASMODIUM VIVAX; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 11844274676     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/426830     Document Type: Article

References (32)

1. Mendis K, Sina BJ, Marchesini P, Carter R. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 2001; 64:97-106.
2. Rieckmann KH, Davis DR, Hutton DC. Plasmodium vivax resistance to chloroquine? Lancet 1989; 2:1183-4.
3. Baird JK, Leksana B, Masbar S, et al. Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels. Am J Trop Med Hyg 1997; 56:621-6.
4. Fidock DA, Nomura T, Talley AK, et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 2000; 6:861-71.
5. Foote SJ, Thompson JK, Cowman AF, Kemp DJ. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. Cell 1989; 57:921-30.
6. Babiker HA, Pringle SJ, Abdel-Muhsin A, Mackinnon M, Hunt P, Walliker D. High-level chloroquine-resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine-resistance transporter gene pfcrt and the multidrug-resistance gene pfmdr1. J Infect Dis 2001; 183:1535-8.
7. Chen N, Russell B, Staley J, Kotecka B, Nasveld P, Cheng Q. Sequence polymorphisms in pfcrt are strongly associated with chloroquine resistance in Plasmodium falciparum. J Infect Dis 2001; 183:1543-5.
8. Djimde A, Doumbo OK, Cortese JF, et al. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med 2001; 344:257-63.
9. Dorsey G, Kamya MR, Singh A, Rosenthal PJ. Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda. J Infect Dis 2001; 183:1417-20.
10. Mayor AG, Gomez-Olive X, Aponte JJ, et al. Prevalence of the K76T mutation in the putative Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene and its relation to chloroquine resistance in Mozambique. J Infect Dis 2001; 183:1413-6.
11. Duraisingh MT, Jones P, Sambou I, von Seidlein L, Pinder M, Warhurst DC. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol Biochem Parasitol 2000; 108:13-23.
12. Nomura T, Carlton JMR, Baird K, et al. Evidence for different mechanisms of chloroquine resistance in 2 Plasmodium species that cause human malaria. J Infect Dis 2001; 183:1653-61.
13. Gervais GW, Trujillo K, Robinson BL, Peters W, Serrano AE. Plasmodium berghei: identification of an mdr-like gene associated with drug resistance. Exp Parasitol 1999; 91:86-92.
14. Hunt P, Cravo PVL, Donleavy P, Carlton JM-R, Walliker D. Chloroquine-resistance in Plasmodium chabaudi: are chloroquine-resistance transporter (crt) and multidrug resistance (mar1) orthologues involved? Mol Biochem Parasitol 2004; 133:27-35.
15. Ferrer-Rodriguez I, Perez-Rosado J, Gervais GW, Peters W, Robinson BL, Serrano AE. Plasmodium yoelii: identification and partial characterization of an MDR1 gene in an artemisinin-resistant line. J Parasitol 2004; 90:152-60.
16. Walliker D, Quakyi IA, Wellems TE, et al. Genetic analysis of the human malaria parasite Plasmodium falciparum. Science 1987; 236:1661-6.
17. Contacos PG, Collins WE, Jeffery GM, Krotoski WA, Howard WA. Studies on the characterization of Plasmodium vivax strains from Central America. Am J Trop Med Hyg 1972; 21:707-12.
18. Brega S, de Monbrison F, Severini C, et al. Real-time PCR for dihydrofolate reductase gene single-nucleotide polymorphisms in Plasmodium vivax isolates. Antimicrob Agents Chemother 2004; 48:2581-7.
19. Carlton J. The Plasmodium vivax genome sequencing project. Trends Parasitol 2003; 19:227-31.
20. Baird JK, Basri H, Subianto B, Patchen LC, Hoffman SL. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am J Trop Med Hyg 1991; 44:547-52.
21. Schwartz IK, Lackrtiz EM, Patchen LC. Chloroquine resistance Plasmodium vivax from Indonesia [letter]. New Engl J Med 1991; 324:927.
22. Garg M, Gopinathan N, Bodhe P, Khirsagar NA. Vivax malaria resistant to chloroquine: case reports from Bombay. Trans R Soc Trop Med Hyg 1995; 89:656-7.
23. Dua VK, Kar PK, Sharma VP. Chloroquine resistant Plasmodium vivax malaria in India. Trop Med Int Health 1996; 1:816-9.
24. Kyaw MP, Kyaw MP, Myint O, et al. Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma) [case report]. Trans R Soc Trop Med Hyg 1993; 87:687.
25. Phillips EJ, Keystone JS, Kain KC. Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America. Clin Infect Dis 1996; 23:1171-3.
26. Soto J, Toledo J, Gutierrez P, et al. Plasmodium vivax clinically resistant to chloroquine in Colombia. Am J Trop Med Hyg 2001; 65:90-3.
27. Alecrim das G, Alecrim W, Macedo V. Plasmodium vivax resistance to chloroquine (R2) and mefloquine (R3) in Brazilian Amazon region. Rev Soc Bras Med Trop 1999; 32:67-8.
28. Carlton JMR, Muller R, Yowell CA, et al. Profiling the malaria genome: a gene survey of three species of malaria parasite with comparison to other apicomplexan species. Mol Biochem Parasitol 2001; 118:201-10.
29. Whitby M. Drug resistant Plasmodium vivax malaria. J Antimicrob Chemother 1997; 40:749-52.
30. Pukrittayakamee S, Imwong M, Looareesuwan S, White NJ. Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria. Acta Trop 2004; 89:351-6.
31. Sattabongkot J, Tsuboi T, Zollner GE, Sirichaisinthop J, Cui L. Plasmodium vivax transmission: chances for control? Trends Parasitol 2004; 20:192-8.
32. Valibayov A, Abdullayev F, Mammadov S, et al. Clinical efficacy of chloroquine followed by primaquine for Plasmodium vivax treatment in Azerbaijan. Acta Trop 2003; 88:99-102.